This article explains the concept of controlling for variables in scientific studies, highlighting its significance in assessing the credibility of research findings. It discusses the distinction between experimental and observational studies, illustrating how control groups and…
Access to obesity drugs in the UK is divided between a slow NHS rollout of tirzepatide and a rapidly growing private market. The NHS aims to provide access over 12 years, starting…
Dozens of lawsuits have been filed against the manufacturers of GLP-1 drugs like Ozempic and Wegovy, alleging that users were not adequately warned about the risk of a rare type o…
During a recent segment on the Today show, co-host Craig Melvin humorously responded to Dylan Dreyer's inquiry about whether he has used GLP-1 medications for weight loss. The exc…
Roche has reported promising results from its mid-stage trial of enicepatide, an obesity drug that helped patients with type 2 diabetes achieve an average weight loss of 15.5% and…
A recent study published in Childhood Obesity highlights a concerning trend among children taking GLP-1 medications for weight management and diabetes. The study found that nearly…
A staggering 90 percent of women with sleep apnea remain undiagnosed, with new wearable technology emerging to address this issue. FDA-cleared smart rings from companies like Sams…
Recent lawsuits have emerged against the makers of GLP-1 drugs like Ozempic and Wegovy, alleging insufficient warnings about a rare vision loss condition known as NAION. While stu…
Heidi Skolnik, a sports nutritionist and exercise physiologist, shares insights from her book, 'Your GLP-1 Game Plan,' offering guidance on how to effectively manage nutrition and…
As the use of GLP-1 medications rises among Americans, experts emphasize the importance of strength training to counteract muscle loss associated with these drugs. Exercise physio…
Numerous lawsuits have been initiated in the United States against companies producing GLP-1 medications, such as Ozempic and Mounjaro, claiming these drugs may lead to a rare eye…
The article examines the adherence challenges faced by individuals using GLP-1 medications for obesity treatment, highlighting factors beyond cost and side effects. It discusses i…
Sofia Carson has come under fire for her appearance at the LACMA Art+Film Gala, with fans expressing concern over Hollywood's extreme beauty standards. The backlash highlights a g…
Beauty companies are racing to address the newly coined term 'Ozempic face' as they develop treatments for facial volume loss linked to rapid weight loss, further complicating the…
Fitness coach Jacob Zemer outlines key strategies to help adults slow muscle loss as they age. He emphasizes the importance of strength training, adequate protein intake, and qual…
NVIDIA and Eli Lilly have both reported impressive quarterly earnings, showcasing their respective growth potential. NVIDIA's revenue surged by over 105% year-over-year, driven by…
Novo Nordisk's stock fell by 7% after the company revealed its long-term growth strategy at a capital markets day, raising investor concerns about its ability to maintain its posi…
In a stunning twist of regulatory fate, the FDA has issued new hair-raising guidelines for users of GLP-1 drugs like Ozempic and Mounjaro, warning of a 37-68% increased risk of ha…